You still around MeSuther13?I just bought this stock a few days ago, having owned OMRI for a while, finding out ZGEN's product should be released before the end of this year if it gets FDA approval, and soon overtake OMRI in sales. It's the first time I have ever "invested" in a company with no viable products/services on the market. A good way to avoid all the other pipe dreams that have come and gone, but this one looks to be different. King has $250 million in sales on their bovine based product, OMRI running about $55 million in their NEW plasma based product, ZGEN is supposed to be safer than both bovine and plasma, and not be constrained by the availability of plasma. I'll probably bail if FDA does not approve it. Another thing is they have a pretty hefty pipeline aside from rhThrombrin. ZGEN has co-developed drugs that generate $3.5 billion in annual sales being part of another company but got spun off as their research extended past the parent company's focus. That's my understanding of things.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra